~4 spots leftby Jun 2026

Fermented Foods Diet for Ulcerative Colitis

Recruiting in Palo Alto (17 mi)
SS
Overseen bySidhartha Sinha, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Stanford University
Disqualifiers: Pregnancy, Low BMI, Severe cardiac, others

Trial Summary

What is the purpose of this trial?

The purpose of this study is to see how a diet that supplements fermented foods effects inflammation and quality of life in patients with mild to moderate Ulcerative Colitis (UC). There is a paucity of research and an enormous need for better understanding of diet and intestinal inflammation. Fermented food have been shown to positively influence inflammatory cytokines and intestinal microbial diversity in healthy volunteers.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop your current medications. It mentions that appropriate medical treatment for Ulcerative Colitis and related conditions will not be withheld, so you may be able to continue your current medications.

What data supports the effectiveness of the treatment Fermented Food-supplemented Diet for Ulcerative Colitis?

Research shows that fermented foods containing probiotics like Bifidobacterium breve and Lactobacillus strains can help improve symptoms in ulcerative colitis by supporting gut health and reducing inflammation.12345

Are fermented foods generally safe for human consumption?

Fermented foods have been consumed safely by humans for thousands of years and are generally considered safe, with some evidence suggesting they may offer health benefits beyond basic nutrition.36789

How is the Fermented Foods Diet treatment for ulcerative colitis different from other treatments?

The Fermented Foods Diet for ulcerative colitis is unique because it focuses on using fermented foods, which contain probiotics (beneficial bacteria) and bioactive molecules, to improve gut health and reduce inflammation. This approach is different from standard treatments as it aims to enhance the intestinal barrier and balance gut microbiota, potentially offering a natural and dietary-based alternative to traditional medications.14101112

Research Team

SS

Sidhartha Sinha, MD

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for men and women over 18 with mild to moderate Ulcerative Colitis (UC), confirmed by diagnosis. Participants must have symptoms, shown by a partial Mayo Score of 2-7, and elevated fecal calprotectin levels. They need to give written consent to join.

Inclusion Criteria

Written informed consent
I am 18 years old or older.
Elevated fecal calprotectin
See 2 more

Exclusion Criteria

Intolerance to fermented food
I am currently pregnant, nursing, or planning to become pregnant.
Individuals diagnosed with a serious medical condition (unless approved in writing by a physician)
See 5 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants in the experimental arm supplement their diet with fermented foods over 10 weeks, while the control arm maintains a regular diet with limited fermented food intake.

10 weeks

Follow-up

Participants are monitored for changes in inflammatory markers, quality of life, and gut microbiome profiles after the treatment phase.

4 weeks

Treatment Details

Interventions

  • Fermented Food-supplemented Diet (Behavioural Intervention)
  • Regular Diet (Behavioural Intervention)
Trial OverviewThe study aims to understand the impact of a diet supplemented with fermented foods on inflammation and life quality in UC patients compared to those on a regular diet. It explores how these foods might affect gut health and inflammatory responses.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Fermented Food-Supplemented DietExperimental Treatment1 Intervention
Patients in this arm will supplement their regular diet by an increasing number of daily servings of fermented food over a period of 10 weeks.
Group II: Regular Diet Control ArmPlacebo Group1 Intervention
Patients in this arm will continue their regular diet throughout the 10 weeks of study with a maximum of 1 serving of fermented foods per day.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+
Dr. Richard A. Miller profile image

Dr. Richard A. Miller

Stanford University

Chief Executive Officer since 2023

Stanford University, MD

Dr. Robert Schott profile image

Dr. Robert Schott

Stanford University

Chief Medical Officer since 2021

University of Michigan, MD

Findings from Research

In a study involving 41 patients with mild to moderate ulcerative colitis (UC), treatment with the synbiotics Bifidobacterium breve strain Yakult and galacto-oligosaccharide (GOS) for one year led to significant clinical improvements as assessed by colonoscopy.
The synbiotics not only improved the clinical status of UC patients but also reduced inflammation markers and altered gut bacteria composition, suggesting a beneficial effect on disease management.
Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study.Ishikawa, H., Matsumoto, S., Ohashi, Y., et al.[2011]
The study found that TK1501 fermented soybeans can alleviate colitis in mice, and this effect is primarily due to bacterial metabolites rather than the presence of live or dead bacteria.
Key metabolites, specifically lipoteichoic acid and peptidoglycan, were identified as the main active ingredients, with lipoteichoic acid enhancing macrophage phagocytosis and peptidoglycan potentially increasing mucin-2 expression, suggesting a mechanism for the anti-inflammatory effects.
Lactobacillus paracasei TK1501 fermented soybeans alleviate dextran sulfate sodium-induced colitis by regulating intestinal cell function.Chen, K., Luo, H., Li, Y., et al.[2023]
Whey fermented with the probiotic Lactobacillus rhamnosus significantly improved gastrointestinal health in a mouse model of ulcerative colitis, reducing disease activity and enhancing blood and tissue health indicators.
The consumption of this fermented whey led to lower levels of pro-inflammatory markers and higher levels of anti-inflammatory cytokines, suggesting it helps maintain intestinal barrier integrity and immune balance.
Protective effects of potential probiotic Lactobacillus rhamnosus (MTCC-5897) fermented whey on reinforcement of intestinal epithelial barrier function in a colitis-induced murine model.Kaur, H., Gupta, T., Kapila, S., et al.[2022]

References

Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. [2011]
Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis. [2018]
Lactobacillus paracasei TK1501 fermented soybeans alleviate dextran sulfate sodium-induced colitis by regulating intestinal cell function. [2023]
Protective effects of potential probiotic Lactobacillus rhamnosus (MTCC-5897) fermented whey on reinforcement of intestinal epithelial barrier function in a colitis-induced murine model. [2022]
Rationale for Using of Bifidobacterium Probiotic Strains-Fermented Milk Against Colitis Based on Animal Experiments and Clinical Trials. [2018]
Health benefits of fermented foods: microbiota and beyond. [2018]
Inclusion of fermented foods in food guides around the world. [2018]
Fermented Foods: Definitions and Characteristics, Impact on the Gut Microbiota and Effects on Gastrointestinal Health and Disease. [2021]
Food fermentation: a safety and nutritional assessment. Joint FAO/WHO Workshop on Assessment of Fermentation as a Household Technology for Improving Food Safety. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Protective effects of fermented rice extract on ulcerative colitis induced by dextran sodium sulfate in mice. [2023]
Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Metabolomic Profile of Ulcerative Colitis Patients in Clinical Remission. [2023]
Profermin is efficacious in patients with active ulcerative colitis--a randomized controlled trial. [2018]